Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06535659Recruiting

VitaFlow LIBERTY Europe

Role: lead

NCT07304427Completed

Alwide Plus China Post-market Clinical Investigation

Role: lead

NCT06597188Not ApplicableEnrolling By Invitation

TAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis

Role: lead

NCT05977257Not Yet Recruiting

VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL）

Role: lead

NCT04655742Not ApplicableUnknown

VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial

Role: lead

NCT04414865Recruiting

VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study

Role: lead

NCT04414878Not ApplicableRecruiting

VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial

Role: lead

NCT03575039Not ApplicableUnknown

VitaFlowTM II Transcatheter Aortic Valve System Study

Role: lead

All 8 trials loaded